Nutrition 21
|
|
Nutrition 21 is pioneering an effort to use patented technology, pharmaceutical research and strategic marketing and distribution partnerships to build its position in therapeutic markets. The Company is targeting the diabetes marketplace and related health markets where poor insulin function is a metabolic risk factor. These include obesity, metabolic syndrome, cardiovascular disease and depression.
|
|
|
Poor insulin function and glucose control are strong bio-markers for
diabetes. Chromium is a trace mineral essential for healthy insulin
function and blood sugar levels. The Company holds 24 U.S. patents for
chromium compounds, their uses and Chromax® chromium picolinate, a
unique form of chromium with superior bioactivity. Twelve (12)
published clinical studies involving over 1500 subjects demonstrate
that supplemental use of Chromax chromium picolinate, at 200 to 1000
mcg has demonstrated an ability to improve glycemic control in people
with or at risk for diabetes.
The patented findings and recent discoveries, including insights into
chromium picolinate’s mechanism of action and the detection of a strong
correlation between low chromium status and the incidence of
cardiovascular disease and diabetes are generating significant
excitement among metabolic researchers. The health benefits of Chromax
use have also been observed in people with high cholesterol, in obese
populations and in people suffering with atypical depression. In
addition, women’s reproductive health is a new area of scientific
interest for chromium picolinate researchers.
Healthcare providers are most likely to rely on FDA approved drugs as
the first course of therapy for patients, particularly those suffering
with high-risk chronic diseases. Therefore, Nutrition 21 relies on
large-scale double-blind placebo-controlled clinical trials as a key
element of its marketing strategy. The company’s objective is to
translate its scientific findings into trusted brands recognized for
their measurable contribution to improving public health and reducing
cost of care. The Company’s plan is to not only earn the trust of
consumers, but to secure an endorsement from healthcare professionals
with the ultimate objective of getting its products adopted as a
standard treatment for diabetes management.
Different from most biotechnology or pharmaceutical companies, the
Company is focused on developing products that are marketed under the
Dietary Supplement Health and Education Act (DSHEA) regulatory pathway.
The Food and Drug Administration’s (FDA) regulations for the supplement
category enable companies to bring products to market in less time and
with less cost than is required for FDA drug approval. In order to
establish credibility among healthcare experts, the company is seeking
an FDA qualified health claim acknowledging the health benefit of its
products in reducing the risk of diabetes and conditions associated
with insulin resistance.
Armed with clinical evidence that promises to reveal remarkable,
clinically measurable effects of its products in therapeutic approaches
to epidemic diseases like diabetes, obesity and depression, Nutrition
21 enjoys the following unique competitive advantages: - An established base business that supports a robust clinical research and business development effort;
- An
expertise in identifying and patenting nutrition therapies addressing
overlapping health markets that affect as many as 25 percent of US
adults;
- A history of successfully patenting its innovations and enforcing its patents;
- Research alliances with leading universities, research institutes and scientists; and
- A
proven track record in leveraging clinical outcomes to build consumer
and trade awareness for its nutrition products through public relations.
Nutrition 21 is fully committed to the responsible marketing of dietary
supplements. The company not only uses pharmaceutical research
standards to establish the safety and efficacy of the products it
markets, but also maintains that commitment through a rigorous quality
assurance program. Good science is the Nutrition 21 hallmark that
distinguishes the Company as a pioneer and a leader in the nutrition
industry.
|
|
|
